Health

Philadelphia, PA, United States – December 2, 2013 – Shire plc (LSE: SHP, NASDAQ: SHPG), announces that its subsidiary Shire US Inc. has entered into an agreement to supply an authorized generic version of its product Adderall XR.  Under the agreement, Sandoz Inc. will market an authorized generic version of Adderall XR® beginning July 1, 2016. […]

A broad range of components for dose-efficient imaging systems, image processing workstations, and cancer treatment technologies, are on display at RSNA in Chicago CHICAGO, Dec. 2, 2013 /PRNewswire/ — Booth 4304 — A new lightweight wireless flat-panel digital X-ray image detector ideal for imaging extremities and for use in neonatal imaging systems is among the imaging components that […]

More than 10,000 people with self-reported and diagnosed type 2 diabetes and more than 6,500 treating-physicians from 26 countries to take part in new survey RIDGEFIELD, Conn. and INDIANAPOLIS, Dec. 2, 2013 /PRNewswire/ — Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) today announced the launch of the largest multinational survey to investigate early […]

Forest acquires exclusive rights to Saphris® in the United States for the treatment of schizophrenia and acute bipolar mania in adults for $240 million plus sales-based milestones and on-going supply payments Saphris is complementary to Forest’s existing CNS franchise and commercial infrastructure Agreement is expected to be immediately accretive to Forest NEW YORK —  December […]

PITTSBURGH, Dec. 1, 2013 /PRNewswire/ — Mylan Inc. (Nasdaq: MYL), one of the world’s leading pharmaceutical companies, and the Elton John AIDS Foundation (EJAF) today announced that they will give a combined $1 million to the Business Leadership Council for a Generation Born HIV Free (BLC) for the elimination of mother-to-child transmission (eMTCT) of HIV […]

Monaco 5 radiation therapy treatment planning system unites capabilities in a single system STOCKHOLM, November 27, 2013 – Monaco® 5, the latest version of Elekta’s Monaco treatment planning system has received 510(k) clearance from the US Food & Drug Administration, making it available for purchase and use in the United States. “Monaco 5 consolidates the […]

Results of Review¹ by Harley Street and University College Hospital London Presented in Online Edition of ‘Radiotherapy and Oncology’ (Green Journal) LONDON, Nov. 27, 2013 /PRNewswire/ — Treating early stage non-small-cell lung cancer (NSCLC) patients with advanced radiotherapy appears to be a viable alternative to surgery, according to researchers who carried out a retrospective comparative study sponsored […]

LISBON, Portugal, Nov. 26, 2013 /PRNewswire/ — Leading oncology centers have reported on advances in stereotactic radiosurgery (SRS) and stereotactic ablative radiotherapy (SABR) treatments at the first Varian Edge™ Radiosurgery Symposium, held at the Champalimaud Centre for the Unknown in Lisbon, Portugal. Experts from leading centers of excellence around the world presented details of the latest in advanced treatment […]

Learning and Innovation Center to address radiation therapy training needs STOCKHOLM, November 25 – Today, Chinese government officials, key Elekta radiotherapy customers in China and members of Elekta’s senior management inaugurated Elekta’s Learning and Innovation Center (LINC) in Beijing. The three-story, 1,800sq m (19,375sq ft) education and training facility is equipped with Elekta radiation therapy […]